Ganglioside GM2

Ganglioside GM2 is a lipid of Sphingolipids (SP) class. Ganglioside gm2 is associated with abnormalities such as Sensory neuropathy, Neuropathy, Autoimmune Diseases, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating and Neuromuscular Diseases. The involved functions are known as Pressure- physical agent, Cytolysis, Inflammation, Complement-Dependent Cytotoxicity and conjugation. Ganglioside gm2 often locates in Membrane, Entire nervous system, Cell surface, Biopsy sample and Lipid Bilayers. The associated genes with Ganglioside GM2 are anti-IgM, Polypeptides, Transgenes, Alleles and Homologous Gene. The related lipids are Ganglioside GA2, QS 21, sulfate-3-glucuronyl paragloboside, Lipopolysaccharides and IV(4)-galactosyl-N-acetylganglioside GD1a. The related experimental models are Disease model.

Cross Reference

Introduction

To understand associated biological information of Ganglioside GM2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Ganglioside GM2?

Ganglioside GM2 is suspected in Tay-Sachs Disease, Gangliosidoses GM2, Sandhoff Disease, Neuropathy, Cytomegalovirus Infections, Niemann-Pick Diseases and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

No disease MeSH terms mapped to the current reference collection.

PubChem Associated disorders and diseases

What pathways are associated with Ganglioside GM2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Ganglioside GM2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Ganglioside GM2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Ganglioside GM2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Ganglioside GM2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Ganglioside GM2?

Disease model

Disease model are used in the study 'Development of GlcNAc-inspired iminocyclitiols as potent and selective N-acetyl-beta-hexosaminidase inhibitors.' (Ho CW et al., 2010) and Disease model are used in the study 'Therapeutic evaluation of GM2 gangliosidoses by ELISA using anti-GM2 ganglioside antibodies.' (Tsuji D et al., 2007).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Ganglioside GM2

Download all related citations
Per page 10 20 50 100 | Total 558
Authors Title Published Journal PubMed Link
Kyrkanides S et al. beta-hexosaminidase lentiviral vectors: transfer into the CNS via systemic administration. 2005 Brain Res. Mol. Brain Res. pmid:15710246
Masson E et al. Glucosamine induces cell-cycle arrest and hypertrophy of mesangial cells: implication of gangliosides. 2005 Biochem. J. pmid:15654767
Moran AP et al. Antibodies induced by ganglioside-mimicking Campylobacter jejuni lipooligosaccharides recognise epitopes at the nodes of Ranvier. 2005 J. Neuroimmunol. pmid:15993494
Usuki S et al. AIDP and CIDP having specific antibodies to the carbohydrate epitope (-NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glc-) of gangliosides. 2005 J. Neurol. Sci. pmid:15850580
Yamato O et al. GM2-gangliosidosis variant 0 (Sandhoff-like disease) in a family of Japanese domestic cats. 2004 Vet. Rec. pmid:15623087
Cressant A et al. Improved behavior and neuropathology in the mouse model of Sanfilippo type IIIB disease after adeno-associated virus-mediated gene transfer in the striatum. 2004 J. Neurosci. pmid:15537895
Kunishige M et al. Isolated cranial neuropathy associated with anti-glycolipid antibodies. 2004 J. Neurol. Sci. pmid:15465085
Aoki H et al. Inhibition of motility and invasiveness of renal cell carcinoma induced by short interfering RNA transfection of beta 1,4GalNAc transferase. 2004 FEBS Lett. pmid:15178323
Andersen SM et al. Synthesis of ganglioside epitopes for oligosaccharide specific immunoadsorption therapy of Guillian-Barré syndrome. 2004 Org. Biomol. Chem. pmid:15064799
Higashi H and Chen NH Ganglioside/protein kinase signals triggering cytoskeletal actin reorganization. 2004 Glycoconj. J. pmid:14973370
Batuwangala T et al. The crystal structure of human CD1b with a bound bacterial glycolipid. 2004 J. Immunol. pmid:14764708
Wendeler M et al. Photoaffinity labelling of the human GM2-activator protein. Mechanistic insight into ganglioside GM2 degradation. 2004 Eur. J. Biochem. pmid:14728689
Yamaguchi A et al. Possible role of autoantibodies in the pathophysiology of GM2 gangliosidoses. 2004 J. Clin. Invest. pmid:14722612
Yamato O et al. Laboratory diagnosis of canine GM2-gangliosidosis using blood and cerebrospinal fluid. 2004 J. Vet. Diagn. Invest. pmid:14974845
Krug LM et al. Vaccination of small cell lung cancer patients with polysialic acid or N-propionylated polysialic acid conjugated to keyhole limpet hemocyanin. 2004 Clin. Cancer Res. pmid:14871967
Wendeler M et al. Recombinant ganglioside GM2 synthase--expression in insect cells and enzyme assay. 2003 Meth. Enzymol. pmid:14579597
Li YT et al. Structural basis for the enzymatic resistance of the GM2 ganglioside. 2003 Meth. Enzymol. pmid:14579580
Mauri L et al. Procedure for separation of GM2 ganglioside species with different ceramide structures by a flash reversed-phase silica gel liquid chromatography. 2003 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:14552811
Brown ER and Ibrahim JG A Bayesian semiparametric joint hierarchical model for longitudinal and survival data. 2003 Biometrics pmid:12926706
Li YT et al. Presence of an unusual GM2 derivative, taurine-conjugated GM2, in Tay-Sachs brain. 2003 J. Biol. Chem. pmid:12829702
Antoine T et al. Large-scale in vivo synthesis of the carbohydrate moieties of gangliosides GM1 and GM2 by metabolically engineered Escherichia coli. 2003 Chembiochem pmid:12740812
Mizutani K et al. Amyotrophic lateral sclerosis with IgM antibody against gangliosides GM2 and GD2. 2003 Intern. Med. pmid:12705795
Odaka M and Yuki N Antibodies to GM2 ganglioside in neurological disorders. 2003 Intern. Med. pmid:12705785
Yamaguchi A et al. Plasmid-based gene transfer ameliorates visceral storage in a mouse model of Sandhoff disease. 2003 J. Mol. Med. pmid:12682727
Rapoport E et al. Ganglioside binding pattern of CD33-related siglecs. 2003 Bioorg. Med. Chem. Lett. pmid:12639556
Shimada Y et al. Effect of GM2 activator protein on the enzymatic hydrolysis of phospholipids and sphingomyelin. 2003 J. Lipid Res. pmid:12576516
Chen HH et al. Suppression of lung metastasis of mouse Lewis lung cancer P29 with transfection of the ganglioside GM2/GD2 synthase gene. 2003 Int. J. Cancer pmid:12455030
Sharma R et al. A single site in human beta-hexosaminidase A binds both 6-sulfate-groups on hexosamines and the sialic acid moiety of GM2 ganglioside. 2003 Biochim. Biophys. Acta pmid:12527415
Irie S et al. Detection of serum anti-ganglioside antibodies by latex agglutination assay in Guillain-Barré syndrome: comparison with ELISA. 2003 Intern. Med. pmid:12857046
Tada M et al. [Steroid-pulse therapy in Guillain-Barré syndrome associated with cytomegalovirus infection: a case report]. 2003 No To Shinkei pmid:12910997
Pelled D et al. Inhibition of calcium uptake via the sarco/endoplasmic reticulum Ca2+-ATPase in a mouse model of Sandhoff disease and prevention by treatment with N-butyldeoxynojirimycin. 2003 J. Biol. Chem. pmid:12756243
Wölfl M et al. Gangliosides inhibit the development from monocytes to dendritic cells. 2002 Clin. Exp. Immunol. pmid:12452834
Martino S et al. Restoration of the GM2 ganglioside metabolism in bone marrow-derived stromal cells from Tay-Sachs disease animal model. 2002 Neurochem. Res. pmid:12374215
Ravasi D et al. Study of interaction of GM2 activator protein with GM2 using circular dichroism and fluorescence spectroscopy. 2002 Neurochem. Res. pmid:12374214
Jeyakumar M et al. Glycosphingolipid lysosomal storage diseases: therapy and pathogenesis. 2002 Neuropathol. Appl. Neurobiol. pmid:12366816
Jeyakumar M et al. An inducible mouse model of late onset Tay-Sachs disease. 2002 Neurobiol. Dis. pmid:12270683
Niazi KR et al. The CD1b structure: antigen presentation adapts to a high-fat diet. 2002 Nat. Immunol. pmid:12145652
Gadola SD et al. Structure of human CD1b with bound ligands at 2.3 A, a maze for alkyl chains. 2002 Nat. Immunol. pmid:12118248
Lopate G et al. Severe sensory ataxia and demyelinating polyneuropathy with IgM anti-GM2 and GalNAc-GD1A antibodies. 2002 Muscle Nerve pmid:12115971
Myerowitz R et al. Molecular pathophysiology in Tay-Sachs and Sandhoff diseases as revealed by gene expression profiling. 2002 Hum. Mol. Genet. pmid:12019216
Alaedini A et al. Detection of anti-ganglioside antibodies in Guillain-Barré syndrome and its variants by the agglutination assay. 2002 J. Neurol. Sci. pmid:11959155
Martino S et al. Absence of metabolic cross-correction in Tay-Sachs cells: implications for gene therapy. 2002 J. Biol. Chem. pmid:11923278
Sango K et al. Lysosomal storage results in impaired survival but normal neurite outgrowth in dorsal root ganglion neurones from a mouse model of Sandhoff disease. 2002 Neuropathol. Appl. Neurobiol. pmid:11849560
Mehta RR et al. In vitro transformation of human congenital naevus to malignant melanoma. 2002 Melanoma Res. pmid:11828255
Guerry P et al. Phase variation of Campylobacter jejuni 81-176 lipooligosaccharide affects ganglioside mimicry and invasiveness in vitro. 2002 Infect. Immun. pmid:11796612
Miljan EA et al. Interaction of the extracellular domain of the epidermal growth factor receptor with gangliosides. 2002 J. Biol. Chem. pmid:11796728
Trindade VM et al. Ganglioside alterations in the central nervous system of rats chronically injected with methylmalonic and propionic acids. 2002 Metab Brain Dis pmid:12083341
Taniguchi M et al. Sites and temporal changes of gangliosides GM1/GM2 storage in the Niemann-Pick disease type C mouse brain. 2001 Brain Dev. pmid:11578853
Gouni-Berthold I et al. Gangliosides GM1 and GM2 induce vascular smooth muscle cell proliferation via extracellular signal-regulated kinase 1/2 pathway. 2001 Hypertension pmid:11711493
Li SC et al. Degradation of G(M1) and G(M2) by mammalian sialidases. 2001 Biochem. J. pmid:11696012